Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF290.00.

Deutsche Bank analyst Emmanuel Papadakis maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

We recently compiled a list of the Morgan Stanley’s 15 Best European AI Stocks. In this article, we are going to take a look ...

Roche Holding AG said profit will probably outpace sales growth this year as the Swiss drugmaker works to keep research costs in check and looks for deals to build its pipeline of experimental ...

Roche said on Thursday it is targeting a continued increase in adjusted earnings per share (EPS) at a high single-digit ...

The company expects sales and core earnings to keep growing this year after beating analysts’ expectations for 2024, and the ...

Roche Holding, a Swiss multinational pharmaceutical and diagnostic giant, acquired the business in 2008 for $3.4 billion and has expanded its reach. Ventana had gone public 12 years earlier ...

Roche Holding is scheduled to report results for 2024 on Thursday. Here is what to know. SALES FORECAST: The Swiss pharma giant's sales for last year are forecast at 60.41 billion Swiss francs ($ ...

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products ...

Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for ...